Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580463 · ClinicalTrials.gov registry record
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,128
- Enrollment target
NCT00580463: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00580463 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580463 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,128 participants
- Enrollment target
Study Summary
The purpose of the study is to collect samples of brain or spine tumors. Memorial Sloan-Kettering Cancer Center would then store them for use by researchers who study brain or spine cancer and try to find better ways of treating it. We will also collect blood and spinal fluid from patients with brain or spine tumors. The blood and spinal fluids are also used for research studies of cancer and its treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,128 participants |
| Start Date | 2000-01 |
| Est. Completion | 2009-03 |
What the finished NCT00580463 record still lists
NCT00580463 is an observational study that tracks outcomes without assigning an intervention. Its 1,128 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00580463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00580463 about?
NCT00580463 is a clinical study titled "Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors". The purpose of the study is to collect samples of brain or spine tumors. Memorial Sloan-Kettering Cancer Center would then store them for use by researchers who study brain or spine cancer and try to find better ways of treating it. We will also collect blood and spinal fluid from patients with brai...
What is the current status of trial NCT00580463?
This trial is currently completed. The enrollment target is 1,128 participants. The study started on 2000-01. Estimated completion is 2009-03.
Who is sponsoring clinical trial NCT00580463?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06445062 · 1,130 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
- NCT04421768 · 1,125 participants · NA
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
- NCT06895148 · 1,125 participants · NA
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia